Huntington’s Disease is Treated for the First Time in Gene Therapy Trial

Huntington’s disease, a deadly degenerative illness, has been treated for the first time in a revolutionary gene therapy trial. The disease is a hereditary illness, typically appearing in adults in their 30s and 40s. The symptoms include mood swings, anger, depression, uncontrolled jerky movements, dementia, and paralysis. There has been no cure or way to minimize its progression. The trial concluded that the treatment had slowed the progression of Huntington’s disease by an average of 75 percent. Additionally, the medication helped protect neurons, resulting in fewer signs of cell death. Sara Tabrizi, director of the University College London’s Huntington’s disease centre, reports that the drug will help people work and live independently for longer. Tabrizi said, “We now have a treatment